AstraZeneca suffers diabetes drug setback for COVID
British pharmaceutical giant AstraZeneca on Monday said that following a trial, its diabetes drug Farxiga was not successful in treating COVID patients at risk of severe complications.
- Next story The best OnePlus phones for 2021
- Previous story Mysterious blackout in Iran threatens to undermine nuclear talks
Explore more
- Motels Get Makeovers Across the U.S.
“Motor lodges.” “High-end motels.” “Exterior-corridor hotels.” Whatever you call them, the “motorist’s... - Study estimates duration of employment loss experienced by adults with kidney failure
A new study estimates the years of employment loss experienced by working-aged... - Rose Holds Slim Masters Lead as Johnson Misses the Cut
After shooting a 75 on Friday, Dustin Johnson, who won the Masters... - What’s the Best Exercise for You? Twins Can Provide an Answer.
Almost everyone responds to the right exercise program, but the right program... - Here’s The Latest News on the Colonial Pipeline Shutdown
The national average for a gallon of regular gasoline rose 2 cents... - Will the Excelsior Pass, New York’s Vaccine Passport, Catch On?
More than 1 million Excelsior passes have been downloaded since they were... - Heat for hypertension in autonomic failure
Patients with autonomic failure—a neurodegenerative disorder characterized by a disabling drop in... - Shohei Ohtani Is Thriving as a Two-Way Star
With the so-called Ohtani rules junked, the Angels’ “super freak” is dominating... - India’s disaster hangs over countries facing COVID-19 surges
Countries worldwide wrestling with new coronavirus surges are trying to ensure they... - Medical Witnesses for Chauvin’s Defense May Begin Testifying
Derek Chauvin’s lawyer will try to combat earlier witnesses’ claims. A protest...